Cardiac Counselling Clinic

Your generous support has enabled us to provide specialist support through our Cardiac Counselling Clinic for people experiencing psychological and behavioural challenges following their heart event. This specialist service is the only one of its kind in Australia.

With your support of the program, we are able to offer our counselling at no cost to our clients, through bulk billing.

Teleheart

Teleheart is a telephone-delivered program designed to support behavioural and emotional recovery. Session duration is 20-45 minutes. The telephone sessions are delivered by expert cardiac lifestyle counsellors.

With your support of the program, we are able to offer our counselling at no cost to our clients.

SCAD Project

This project will involve both qualitative and quantitative research with SCAD survivors with the aim of identifying their specific stresses and concerns, and their support needs and preferences.

We will then develop and deliver an effective support program to address the psychosocial needs of SCAD survivors. This project is being undertaken in conjunction with colleagues from the Victor Chang Cardiac Research Institute and SCAD Research Inc.

The study is due to commence in mid-2021.

Cardiac Emotions Study

In this study we are assessing a broad range of psychological, social and behavioural symptoms of cardiac emotions. We will report on the prevalence and severity of these symptoms in a sample of up to 350 cardiac event survivors, and will investigate the relationship of these symptoms to commonly assessed constructs such as anxiety, depression and quality of life, as well as a set of emotional thermometers.

Back on Track Trial

The Back on Track trial is a randomised controlled trial (RCT) comparing two modes of delivering the Back on Track telehealth support program: online only, and online plus telephone support.

The study will be completed by mid-2022.

Beating Heart Problems Survival Study

Following the Beating Heart Problems Program trial program conducted in 2010-12, in this follow-up study we are investigating the impact of program participation on patients’ 14-year survival status.

This project will be completed by December 2022.